In its fight against counterfeit and inferior medicines, the EU responded with the anti-counterfeiting directive 2011/62 / EU. As of February 9, 2019, with few exceptions, prescription drugs can only be marketed with a security label and serial number. For pharmaceutical companies, implementing the EU Directive is a difficult task. According to the estimates of pharmaceutical manufacturers, the cost of implementing each EU pharmaceutical production line is hundreds of thousands of Euros.\ http://www.fqpackaging.com/products/tamper-evident-bags/